KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $71.1 million.

  • Globus Medical's Depreciation & Amortization (CF) rose 624.23% to $71.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $276.1 million, marking a year-over-year increase of 743.35%. This contributed to the annual value of $254.0 million for FY2024, which is 7551.21% up from last year.
  • Globus Medical's Depreciation & Amortization (CF) amounted to $71.1 million in Q3 2025, which was up 624.23% from $70.6 million recorded in Q2 2025.
  • Globus Medical's 5-year Depreciation & Amortization (CF) high stood at $71.2 million for Q4 2023, and its period low was $16.8 million during Q3 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $19.1 million (2021), whereas its average is $39.2 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 1151.59% in 2022, then skyrocketed by 32082.79% in 2023.
  • Quarter analysis of 5 years shows Globus Medical's Depreciation & Amortization (CF) stood at $16.8 million in 2021, then increased by 0.48% to $16.9 million in 2022, then surged by 320.83% to $71.2 million in 2023, then fell by 4.12% to $68.2 million in 2024, then grew by 4.25% to $71.1 million in 2025.
  • Its Depreciation & Amortization (CF) was $71.1 million in Q3 2025, compared to $70.6 million in Q2 2025 and $66.1 million in Q1 2025.